SCHEMBL2234262

SCHEMBL2234262

Cc1ccc(C2=Cc3c(ccc(C)c3-c3ccc(-c4ccccc4)cc3)C2[Si](C)(C)C2C(c3ccc(C)o3)=Cc3c2ccc(C)c3-c2ccc(-c3ccccc3)cc2)o1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.40
PTGS2 P35354 1/20 0.40
ALDH1A1 P00352 4/20 0.37
HPGD P15428 4/20 0.37
MEN1 O00255 3/20 0.37
MAPT P10636 3/20 0.37
KMT2A Q03164 3/20 0.37
KDM4E B2RXH2 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
LMNA P02545 2/20 0.37
PKM P14618 2/20 0.37
ALOX12 P18054 1/20 0.37
HTT P42858 1/20 0.37
ADORA2A P29274 2/20 0.34
ADORA1 P30542 2/20 0.34
GLA P06280 2/20 0.33
GAA P10253 2/20 0.33
ALOX15 P16050 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2235899 0.98 PTGS1 (0.42) PTGS1PTGS2ALDH1A1HPGDMEN1
SCHEMBL15712970 0.90 PTGS1 (0.37) PTGS1PTGS2ALDH1A1HPGDMEN1
SCHEMBL2233701 0.86 IKBKB (0.35) PTGS1PTGS2ALDH1A1HPGDMEN1
SCHEMBL2235954 0.86 NPC1 (0.32) ALDH1A1KDM4ENPC1RAB9A
SCHEMBL2234973 0.86 GSK3B (0.37) PTGS2ALDH1A1HPGDMEN1MAPT
SCHEMBL2384989 0.85 SMO (0.32) PTGS2LMNA
SCHEMBL2234380 0.84 SMN1; SMN2 (0.32) PTGS1PTGS2ALDH1A1MAPTKDM4E
SCHEMBL22499757 0.84 PTGS1 (0.39) PTGS1PTGS2ALDH1A1HPGDMEN1
SCHEMBL2234850 0.84 KDM4E (0.31) ALDH1A1HPGDMEN1MAPTKMT2A
SCHEMBL17066784 0.83 PTGS1 (0.40) PTGS1PTGS2ALDH1A1HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2360163-B1 METALLOCENE COMPLEX AND METHOD FOR POLYMERIZING OLEFIN JAPAN POLYPROPYLENE CORP (JP) 2014-06-25 EP disclosed
US-8461365-B2 Metallocene complex and polymerization method of olefin JAPAN POLYPROPYLENE CORPORATION (JP) 2013-06-11 US disclosed
US-20110230622-A1 METALLOCENE COMPLEX AND POLYMERIZATION METHOD OF OLEFIN JAPAN POLYPROPYLENE CORPORATION (JP) 2011-09-22 US disclosed
EP-2360163-A1 METALLOCENE COMPLEX AND METHOD FOR POLYMERIZING OLEFIN Japan Polypropylene Corporation (JP) 2011-08-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230622-A1 METALLOCENE COMPLEX AND POLYMERIZATION METHOD OF OLEFIN ALOX12, ALOX15, ALOX15B PTGS1 199/4885PTGS2 198/4885ALDH1A1 477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.